Navigation Links
Synterra Energy Merges Key Technologies to Commercialize Next Generation Integrated Bio-refinery
Date:7/26/2011

SACRAMENTO, Calif., July 26, 2011 /PRNewswire/ -- Synterra Energy, Inc. announced today the merger of key intellectual property and assets for waste biomass conversion from Pacific Renewable Fuels and Chemicals (Sacramento, California) and Red Lion Bio-Energy (Toledo, Ohio).  With the merger, Synterra will launch the commercialization of next generation integrated bio-refineries for the economic production of renewable fuels, chemicals and power from waste biomass in distributed plants.

"The Red Lion thermochemical conversion system and the Pacific Renewable Fuels and Chemicals catalytic synthesis process are industry leading technologies in their own right," said Robert Schuetzle, CEO of Synterra Energy, Inc.   "The integration of our two technologies creates a seamless proprietary biomass conversion system under a single commercial provider.  The resultant innovative process integration is a design that provides process efficiencies, lowers unit capital cost, reduces the risk of securing adequate feedstock supplies, and mitigates technology risk of mixing and matching multiple platforms from separate process vendors."

In 2009, the Synterra team, along with its project partners, was awarded a $25 million Department of Energy grant to demonstrate the commercial readiness of its integrated bio-refinery (IBR) technologies.   The 30-barrel per day demonstration project was initiated in 2010 and is the third scale up of the Synterra technologies, following years of R&D and pilot plant operations.

Synterra's integrated bio-refineries produce renewable fuels, chemicals and/or electricity with less impact on the environment and higher energy efficiency compared to other conversion processes.  As an example, Synterra's synthetic diesel is a high-quality, zero -sulfur renewable fuel that is a direct replacement for conventional petroleum-derived diesel, with 89% lower greenhouse gas emissions than petroleum derived diesel fuel.

"Synterra Energy and its legacy organizations, Pacific Renewable Fuels and Chemicals and Red Lion Bio-Energy, have recruited top technical and business veterans from the alternative energy, petrochemical, multi modal transportation and logistics, catalyst, and environmental industries with extensive experience in research, development, demonstration and commercialization of new technologies.  With this talented team of professionals, Synterra's integrated approach to process design and experience in modularization of distributed plants, we have a  compelling formula for further commercial success," states Synterra Energy Chairman, Alex Johnson.

Contact:

Synterra Energy
1-888-714-5450 x250


'/>"/>
SOURCE Synterra Energy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Conducting energy on a nano scale
2. Story tips from the Department of Energys Oak Ridge National Laboratory, July 2011
3. Magnetic memory and logic could achieve ultimate energy efficiency
4. Inkjet printing could change the face of solar energy industry
5. Department of Energy projects win 36 R&D100 Awards for 2011
6. Prototype demonstrates success of advanced new energy technology
7. Unprecedented international meeting releases preliminary vision for our energy future
8. High voltage! Power experts pull out all the stops at international energy meeting
9. VG Energys Lipid Enhancement Technology Independently Confirmed in First Phase of Testing for Potential Commercial Production of Biofuels
10. Pennington Biomedical Research Center Study Suggests Decreases in U. S. Occupation Energy Levels a Significant Trigger of Obesity Epidemic
11. Activated graphene makes superior supercapacitors for energy storage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , Jan. 24, 2017  Asterias Biotherapeutics, Inc. ... field of regenerative medicine, today announced positive efficacy ... clinical trial that showed additional motor function improvement ... million AST-OPC1 cells in AIS-A patients with complete ... of upper extremity motor function is critically important ...
(Date:1/24/2017)... Switerland (PRWEB) , ... January 24, 2017 , ... ... first commercially available malaria Plasmodium falciparum culture panels with standard concentrations of histidine ... which are available in a range of concentrations from six different malaria strains, ...
(Date:1/24/2017)... , ... January 23, 2017 , ... Oklahoma City based ... newest client for the firm’s PERFEQTA software and legacy product QC Manager 2.0. ... the dynamic team at CJBC and thrilled that they have decided to implement PERFEQTA ...
(Date:1/24/2017)... , Jan. 23, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: ... into an underwriting agreement with Rodman & Renshaw, a ... as sole book running manager and representative of several underwriters, ... a firm commitment basis a minimum of 2,105,264 shares ... to purchase a minimum of 1,052,632 shares of common ...
Breaking Biology Technology:
(Date:1/18/2017)... -- In vitro diagnostic (IVD) companies were very active in ... Kalorama Information expects that trend to continue – though ... uncertainty in reimbursement and healthcare reform in ... acquisitions landscape. Instead of looking to buy technology, the ... of their home country and also to increase their ...
(Date:1/12/2017)... Jan. 12, 2017  New research undertaken by Fit ... the future.  1,000 participants were simply asked which office technology ... we may consider standard issue.  Insights on what will ... also gathered from futurists and industry leaders including Penelope ... Canton .  Some of these findings ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
Breaking Biology News(10 mins):